title: [Efficacy of the NS3-4A protease inhibitor telaprevir in patients with chronic hepatitis C].
authors.affiliation: Department of Hepatology, Sapporo Kosei General Hospital.
authors.forename: Itaru
authors.initials: I
authors.lastname: Ozeki
authors.forename: Yoshiyasu
authors.initials: Y
authors.lastname: Karino
authors.forename: Joji
authors.initials: J
authors.lastname: Toyota
mesh_terms: D000328:Adult; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000008:administration & dosage / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000008:administration & dosage; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage; D012254:Ribavirin / Q000008:administration & dosage
chemical_list: D016898:Interferon-alpha; D009842:Oligopeptides; D011480:Protease Inhibitors; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C486464:telaprevir; C100416:peginterferon alfa-2a